IP Library Granted Patent US 8,597,901
Granted Patent B2
US 8,597,901 · App. 13/525,086 · Granted Dec 3, 2013

2,5-diketo-L-gluconic acid reductases and methods of use

Inventors: Mark Donnelly (Warrrensville, IL); William H. Eschenfeldt (St. Charles, IL); Jonathan Trent (La Silva Beach, CA)
Assignee: Danisco US Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,597,901
App. No.
13/525,086
Granted
Dec 3, 2013
Kind
B2
Abstract

Described herein are novel nucleic acids, proteins and methods that can be used to provide new catalysts with desirable traits for industrial processes. In particular, novel reductases isolated from the environment using PCR methods are described.

Claims (14)

1. A method for identifying a 2,5-diketo-L-gluconic acid reductase comprising:

a) isolating nucleic acid molecules having homology to 2,5-diketo-L-gluconic acid reductase gene sequences from environmental samples that contain nucleic acids; comprising:

(i) designing a set of degenerate primers SEQ ID NO: 11 and SEQ ID NO: 12 based on known 2,5-diketo-L-gluconic acid reductase or morphine dehydrogenase-gene sequences from various organisms;

(ii) amplifying the environmental sample nucleic acid using the degenerate primers in a suitable polymerase chain reaction;

(iii) identifying and cloning the amplified 2,5-diketo-L-gluconic acid reductase sequences; and

(iv) expressing the amplified, cloned 2,5-diketo-L-gluconic acid reductase sequences as protein molecules; and

b) screening said molecules for 2,5-diketo-D-gluconic acid reductase activity, wherein said molecules having 2,5-diketo-D-gluconic acid reductase activity are identified as a 2,5-diketo-L-gluconic acid reductase.

2. A method according to claim 1 ,wherein the degenerate primers are designed based on the 2,5-diketo-L-gluconic acid reductase gene from Corynebacterium.

3. A method according to claim 1 ,wherein the degenerate primers are designed based on 2,5-diketo-L-gluconic acid reductase and/or morphine dehydrogenase genes.

4. A method according to claim 1 , wherein the degenerate primer is SEQ ID NO: 11 or SEQ ID NO: 12.

5. A method according to claim 1 ,further comprising constructing site specific mutants of isolated nucleic acid molecules having homology to 2,5-diketo-D-gluconic acid reductase gene.

6. A method according to claim 5 , wherein the degenerate primers are SEQ ID NO: 42 and SEQ ID NO: 43.

7. A method according to claim 1 ,wherein the environmental sample is pond water.

8. A method according to claim 1 ,wherein the environmental sample is soil from deciduous forest.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 30, 2013
From: THE UNIVERSITY OF CHICAGO
To: GENENCOR INTERNATIONAL, INC.
Reel/Frame 030908/0669 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 30, 2013
From: ESCHENFELDT, WILLIAM H.; DONNELLY, MARK; TRENT, JONATHAN
To: THE UNIVERSITY OF CHICAGO
Reel/Frame 030908/0708 →
CHANGE OF NAME Recorded Jul 30, 2013
From: GENENCOR INTERNATIONAL, INC.
To: DANISCO US INC.
Reel/Frame 030920/0964 →
Continuity (7)
Continuation 13041176 · Mar 4, 2011
Continuation 12487497 · Jun 18, 2009
Continuation 12050455 · Mar 18, 2008
Division 11015039 · Dec 17, 2004
Continuation 10418401 · Apr 17, 2003
Division 09684385 · Oct 4, 2000
Related Publication 20120322095A1 · Dec 20, 2012